Core Viewpoint - 博士眼镜 is expanding its presence in the smart eyewear sector and enhancing its national channel layout through a newly approved issuance of convertible bonds totaling up to 375 million yuan [1][2]. Group 1: Fundraising and Investment Plans - 博士眼镜 plans to raise up to 375 million yuan through convertible bonds, with key investments directed towards the construction and upgrade of smart eyewear stores, operational management center, brand building, and digital platform upgrades [2]. - The company intends to allocate 180 million yuan to open 225 new stores in major cities and upgrade existing stores, focusing on first-tier, new first-tier, and second-tier cities [2]. - Upon project completion, the company anticipates an average annual revenue of 310 million yuan and an average profit of approximately 33.2 million yuan, with a tax-adjusted internal rate of return of 14.05% [2]. Group 2: Company Performance and Market Position - 博士眼镜 has a total of 584 stores nationwide and has shown revenue fluctuations over recent years, with revenues of 888 million yuan in 2021, 962 million yuan in 2022, 1.176 billion yuan in 2023, and 1.203 billion yuan in 2024 [4]. - In the first three quarters of 2025, the company reported revenues of 1.08 billion yuan, a year-on-year increase of 18.05%, and a net profit of 87.83 million yuan, up 5.21% [4]. - The company has optimized its product structure and channel development, with significant revenue growth in optical glasses and fitting services, achieving 451 million yuan in revenue in the first half of 2025 [4][6]. Group 3: Industry Context and Strategic Initiatives - The demand for professional optical services and smart wearable products is increasing due to consumer upgrades, prompting 博士眼镜 to enhance service levels through smart store expansions and service upgrades [3]. - The company has initiated the "Smart Vision Ecosystem" plan and is recognized as a potential leader in AI eyewear, collaborating with brands like 雷鸟创新 and 星纪魅族 to develop innovative products [6]. - 博士眼镜's total assets have grown from 738 million yuan in 2020 to 1.253 billion yuan in 2024, with a historical high of 1.331 billion yuan reported by the end of Q3 2025 [6].

Group 1 - The core stock price of Dr. Optical (300622) closed at 33.83 yuan on January 19, 2026, down by 1.26% with a turnover rate of 11.09% and a trading volume of 172,800 lots, amounting to a transaction value of 589 million yuan [1] Group 2 - On January 19, 2026, the net outflow of main funds was 23.56 million yuan, indicating a cautious attitude from major investors [2][3] - Dr. Optical has received approval from the China Securities Regulatory Commission for the registration of its convertible bonds to be issued to unspecified objects, which is valid for 12 months from the date of approval [2][3]

Core Viewpoint - The company, 博士眼镜, has received approval from the China Securities Regulatory Commission to issue convertible bonds to unspecified investors, which is a significant step for its financing strategy [1][2]. Group 1: Stock Performance - As of January 19, 2026, 博士眼镜's stock closed at 33.83 yuan, down 1.26% from the previous trading day [1]. - The stock opened at 34.68 yuan, reached a high of 34.69 yuan, and a low of 33.75 yuan, with a trading volume of 5.89 billion yuan and a turnover rate of 11.09% [1]. Group 2: Regulatory Approval - The company has received a formal approval (证监许可〔2026〕84号) from the China Securities Regulatory Commission for the registration of its application to issue convertible bonds [1]. - The approval is valid for 12 months from the date of issuance and requires the company to adhere strictly to the submitted documents and issuance plan [1].

Core Viewpoint - The professional chain sector experienced a slight increase of 0.49% on January 19, with Kid King leading the gains, while the Shanghai Composite Index rose by 0.29% and the Shenzhen Component Index increased by 0.09% [1] Group 1: Market Performance - The closing price of Kid King was 11.71, reflecting a rise of 3.45% with a trading volume of 810,000 shares and a transaction value of 92.36 million [1] - Aiyingshi closed at 18.47, up by 2.90%, with a trading volume of 102,800 shares and a transaction value of 18.5 million [1] - Huazhi Wine's closing price was 17.14, showing an increase of 0.82% with a trading volume of 33,700 shares and a transaction value of 57.70 million [1] - Tianyin Holdings closed at 10.62, up by 0.38%, with a trading volume of 256,600 shares and a transaction value of 271 million [1] - Jifeng Technology closed at 8.69, reflecting a rise of 0.23% with a trading volume of 204,400 shares and a transaction value of 176 million [1] - Boshiyanjing closed at 33.83, down by 1.26%, with a trading volume of 172,800 shares and a transaction value of 589 million [1] - Aishide closed at 13.11, down by 1.87%, with a trading volume of 275,000 shares and a transaction value of 36.2 million [1] Group 2: Capital Flow - The professional chain sector saw a net inflow of 47.10 million from main funds, while retail investors experienced a net outflow of 70.20 million [1] - Kid King had a main fund net inflow of 97.03 million, accounting for 10.51% of the total, while retail investors had a net outflow of 91.11 million, representing -9.87% [2] - Tianyin Holdings recorded a main fund net inflow of 8.36 million, with retail investors experiencing a net outflow of 27.91 million [2] - Jifeng Technology had a main fund net inflow of 7.14 million, while retail investors saw a net outflow of 4.01 million [2] - Aiyingshi experienced a slight main fund net outflow of 0.08 million, with retail investors having a net inflow of 0.87 million [2] - Huazhi Wine had a main fund net outflow of 1.95 million, with retail investors experiencing a net outflow of 1.94 million [2] - Boshiyanjing faced a significant main fund net outflow of 23.56 million, while retail investors had a net inflow of 7.51 million [2] - Aishide had a main fund net outflow of 39.83 million, with retail investors seeing a net inflow of 38.36 million [2]

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 博士眼镜(300622.SZ)公告称，公司收到中国证监会出具的批复，同意公司向不特定对象发行可转换公 司债券的注册申请。批复自同意注册之日起12个月内有效，公司需在规定期限内办理相关事项，并及时 履行信息披露义务。 ...

格隆汇1月18日丨博士眼镜(300622.SZ)发布公告，公司于近日收到中国证监会出具的《关于同意博士眼 镜连锁股份有限公司向不特定对象发行可转换公司债券注册的批复》(证监许可〔2026〕84号)，批复文 件的主要内容如下： 一、同意你公司向不特定对象发行可转换公司债券的注册申请。 二、你公司本次发行应严格按照报送深圳证券交易所的申报文件和发行方案实施。 三、本批复自同意注册之日起12个月内有效。 四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时报告深圳证券交易所并按有 关规定处理。 ...

证券代码：300622 证券简称：博士眼镜 公告编号：2026-002 博士眼镜连锁股份有限公司 关于向不特定对象发行可转换公司债券申请 获得中国证券监督管理委员会同意注册批复的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 博士眼镜连锁股份有限公司（以下简称"公司"）于近日收到中国证券监督 管理委员会出具的《关于同意博士眼镜连锁股份有限公司向不特定对象发行可 转换公司债券注册的批复》（证监许可〔2026〕84 号），批复文件的主要内 容如下： 一、同意你公司向不特定对象发行可转换公司债券的注册申请。 二、你公司本次发行应严格按照报送深圳证券交易所的申报文件和发行方案 实施。 三、本批复自同意注册之日起 12 个月内有效。 四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时 报告深圳证券交易所并按有关规定处理。 公司董事会将按照上述批复文件和相关法律法规的要求以及公司股东会的 授权，在规定期限内办理本次向不特定对象发行可转换公司债券的相关事项，并 及时履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 博士眼镜连锁股份有限公司 董 ...

博士眼镜公告称，近日收到中国证监会《关于同意博士眼镜连锁股份有限公司向不特定对象发行可转换 公司债券注册的批复》。批复同意公司发行申请，要求按报送深交所的申报文件和方案实施，有效期12 个月。发行结束前，若发生重大事项需及时报告深交所并处理。董事会将在规定期限内办理发行相关事 宜，及时披露信息。 ...

Market Overview - The professional chain sector experienced a decline of 1.46% on January 16, with Doctor Glasses leading the drop [1] - The Shanghai Composite Index closed at 4101.91, down 0.26%, while the Shenzhen Component Index closed at 14281.08, down 0.18% [1] Individual Stock Performance - Ji Feng Technology (300022) rose by 3.21% to close at 8.67, with a trading volume of 298,500 shares and a turnover of 256 million [1] - Ai Ying Shi (603214) increased by 0.34% to 17.95, with a trading volume of 62,800 shares and a turnover of 112 million [1] - Yuan Shi De (002416) fell by 1.18% to 13.36, with a trading volume of 267,900 shares and a turnover of 358 million [1] - Hai Zi Wang (301078) decreased by 1.65% to 11.32, with a trading volume of 640,100 shares and a turnover of 722 million [1] - Hua Zhi Jiu Hang (300755) dropped by 1.79% to 17.00, with a trading volume of 48,100 shares and a turnover of 82.1 million [1] - Tian Yin Holdings (000829) fell by 2.04% to 10.58, with a trading volume of 440,600 shares and a turnover of 466 million [1] - Doctor Glasses (300622) declined by 4.52% to 34.26, with a trading volume of 262,900 shares and a turnover of 911 million [1] Capital Flow Analysis - The professional chain sector saw a net outflow of 84.09 million from institutional investors, while retail investors had a net inflow of 63.08 million [1] - The table indicates that Ji Feng Technology had a net inflow of 33.16 million from institutional investors, while retail investors had a net outflow of 25.34 million [2] - Doctor Glasses experienced a significant net outflow of 107 million from institutional investors, with a net inflow of 96.43 million from retail investors [2]

证券日报网讯1月15日，博士眼镜（300622）在互动平台回答投资者提问时表示，公司致力于智能眼 镜"最后一公里"的验配服务，目前，公司已与业内头部智能眼镜厂商阿里夸克、星纪魅族、雷鸟创新、 XREAL、界环、李未可、小米mijia等品牌开展合作。公司将充分发挥自身在品牌、渠道、产品、服务 等方面的优势，为消费者创造舒适清晰视界、助力美好生活。目前公司智能眼镜业务的相关营收占比极 小，请注意投资风险。 ...